Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-label clinical study
This clinical trial has been registered on the Chinese Clinical Trial Registry. Clinical trial information: ChiCTR2500102333.
Authors
- Jie Ma (ORCID: https://orcid.org/0000-0001-5346-8457)
- Lihua Yang (ORCID: https://orcid.org/0000-0003-2570-076X)
- Cuizhen Liu
- Yanfeng Jiang (ORCID: https://orcid.org/0000-0002-5006-5190)
- Fuchao Ma
- Xiang Fang (ORCID: https://orcid.org/0000-0001-8609-2337)
- Jie Liu (ORCID: https://orcid.org/0009-0005-7275-2214)
- Ning Mo (ORCID: https://orcid.org/0000-0002-8916-7178)
- Jie Zeng (ORCID: https://orcid.org/0000-0002-8582-7319)
- Zhiming Zeng
- Jing Tang (ORCID: https://orcid.org/0000-0003-3100-1842)
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Jiangsu Hengrui Medicine (China) (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jgo-2025-721
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00